Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-23
    E.g., 2018-10-23

Archive Search

Pages

1402 items
12:32 PM, Oct 19, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Reports say Innovent seeking $422M IPO in Hong Kong

Innovent Biologics Inc. (Suzhou, China) did not respond to inquiries regarding reports that the company is seeking to raise $422 million in an IPO on the Hong Kong stock exchange, which would value the company...
4:07 PM, Oct 11, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Gene therapy developer Orchard proposes IPO

Orchard Therapeutics Ltd. (London, U.K.) proposed to raise up to $172.5 million in an IPO on NASDAQ. J.P. Morgan, Goldman Sachs, Cowen and Wedbush PacGrow are underwriters. Orchard is developing autologous ex vivo lentiviral gene therapies...
1:14 PM, Oct 05, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

New IPO filings include NGM, Arog, Gamida

Three biotechs filed late Sept. 28 to go public on NASDAQ, adding new companies to a 2018 class of IPOs that could surpass 2015's record for funds raised. The group includes NGM Biopharmaceuticals Inc. (South...
12:26 PM, Sep 28, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Shanghai Henlius to move forward with Hong Kong listing

Fosun Pharmaceutical Group Co. Ltd. (Shanghai:600196; HKSE:2196) said on Sept. 27 its board approved a resolution to list Shanghai Henlius Biotech Inc. (Shanghai, China) on the Hong Kong stock exchange. Shanghai Henlius, a JV between Fosun...
11:42 AM, Sep 28, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

PhaseBio files for $86.3M NASDAQ IPO

PhaseBio Pharmaceuticals Inc. (Malvern, Pa.) proposed on Sept. 21 to raise $86.3 million in an IPO on NASDAQ underwritten by Citigroup, Cowen, Stifel and Needham. On Sept. 7, PhaseBio raised $34 million in a series...
11:03 AM, Sep 28, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Gene therapy play LogicBio proposes IPO

Gene therapy company LogicBio Therapeutics Inc. (Cambridge, Mass.) proposed to raise up to $86 million in an IPO on NASDAQ underwritten by Jefferies, Barclays, William Blair and Chardan. LogicBio is developing gene therapies to address rare...
9:33 AM, Sep 21, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Ex-Kite execs prep quick IPO for CAR T play Allogene

Cell therapy start-up Allogene Therapeutics Inc. (South San Francisco, Calif.) filed to raise up to $100 million in an IPO on NASDAQ underwritten by Goldman Sachs, J.P. Morgan, Cowen and Jefferies. Launched in April with...
9:32 AM, Sep 21, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Equillium proposes $86.3M IPO

Autoimmune and inflammatory disease company Equillium Inc. (La Jolla, Calif.) proposed to raise up to $86.3 million on Sept. 17 in an IPO on NASDAQ underwritten by Jefferies, Leerink and Stifel. The company has U.S. and...
9:31 AM, Sep 21, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

WuXi AppTec queues up for Hong Kong listing

Less than five months after its IPO in Shanghai, WuXi AppTec Co. Ltd. (Shanghai:603259) proposed Sept. 18 to list on the Hong Kong stock exchange in an offering underwritten by Morgan Stanley Asia, Huatai Financial...
3:44 PM, Sep 13, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Kodiak files for IPO

Ophthalmic company Kodiak Sciences Inc. (Palo Alto, Calif.) filed to raise $100 million in an IPO on NASDAQ underwritten by Morgan Stanley, BofA Merrill Lynch, Barclays and Chardan. Using its antibody biopolymer conjugate (ABC) platform, Kodiak...

Pages